Michael E. Berens

Translational Genomics Research Institute — United States

Medicine · Health Sciences

72h-index25.6kcitations578works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(242), Cancer Genomics and Diagnostics(55), Cancer, Hypoxia, and Metabolism(47), ATP Synthase and ATPases Research(39), Radiopharmaceutical Chemistry and Applications(37)

Publications574 total

Molecular profiling of glioblastoma-derived extracellular vesicles identifies small nucleolar RNAs as candidate liquid biomarkers for radiation- induced senescence
2025Open Access
BIOM-47. DECIPHERING GLIOBLASTOMA HETEROGENEITY: INTEGRATING MOLECULAR SIGNATURES AND GENOMIC LANDSCAPES TO PREDICT DRUG SENSITIVITY AND ADVANCE PRECISION ONCOLOGY
Neuro-Oncology·2025Open Access
Androgen loss weakens anti-tumor immunity and accelerates brain tumor growth 3761
The Journal of Immunology·2025Open Access
DDDR-69. Discovery, validation and deployment of a molecular signature of vulnerability to GB13 in an early stage GBM clinical trial
Neuro-Oncology·2025Open Access
BIOM-44. UTILIZING ALIGNMENT-FREE CLASSIFICATION OF CELL-FREE DNA SEQUENCING READS TO MONITOR TUMOR BURDEN IN PRIMARY BRAIN TUMORS
Neuro-Oncology·2025Open Access
EXTH-38. Arsenic trioxide and the MNK1 inhibitor AUM001 exert synergistic anti-glioblastoma effects by modulating key translational, cell cycle, and transmembrane transport pathways
Neuro-Oncology·2025Open Access
BIOM-77. MUTATION PROFILE CONCORDANCE BETWEEN TARGETED NEXT-GENERATION SEQUENCING OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS AND LONGITUDINAL PLASMA AND CEREBROSPINAL CIRCULATING TUMOR DNA SAMPLES
Neuro-Oncology·2025Open Access
Abstract A036: The recombinant immunotoxin GB13 demonstrates significant therapeutic potential for H3.3K27M mutant DIPG with its efficacy linked to the activation of Golgi-to-ER retrograde transport pathways
Cancer Research·2025
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma
UNC Libraries·2025Open Access
NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer
Frontiers in Immunology·2025· 2 citedOpen Access
Cell-Free DNA Sequencing Uncovers the Longitudinal Consequences of Temozolomide Treatment and Host Co-Culture in Glioblastoma
2025Open Access
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma
Acta Neuropathologica Communications·2025Open Access
Abstract 4562: Bespoke sequencing of enriched and normalized amplicons increases on-target rate and reduces background noise for circulating tumor DNA detection and quantification
Cancer Research·2025· 1 cited
Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
Journal of Translational Medicine·2025· 2 citedOpen Access
Feasibility of enriched amplicon circulating tumor DNA sequencing to detect minimal residual disease (MRD) after prostatectomy in localized prostate cancer.
Journal of Clinical Oncology·2025· 2 cited
Investigation of the Combined Application of Leading-Edge Tubercles and Trailing-Edge Serration on AAM Propellers in Terms of Aeroacoustics Using Lattice-Boltzmann Method
2025· 1 cited
BIOM-64. EXPLOITING CELL-FREE DNA TO DISSECT MECHANISMS OF RESISTANCE TO TEMOZOLOMIDE IN GLIOBLASTOMA CELLS
Neuro-Oncology·2024Open Access
DDDR-36. LOOKING AROUND THE CORNER: PREDICTING SYNERGY OR FUTILITY TO COMBINATION OF ARSENIC TRIOXIDE PLUS MNK1 INHIBITORS IN GLIOBLASTOMA
Neuro-Oncology·2024Open Access
EPCO-44. SPATIAL TRANSCRIPTOMICS ENABLES STATISTICAL MODELING OF SEX DIFFERENCE IN GENE CO-EXPRESSION NETWORK AND IMMUNE LANDSCAPE OF GLIOBLASTOMA
Neuro-Oncology·2024Open Access
EPCO-23. LONGITUDINAL TRACKING AND LONG-READ CHROMATIN FIBER SEQUENCING OF HUMAN ASTROCYTES WITH TELOMERE DYSFUNCTION REVEALED ALTERED CHROMATIN ACCESSIBILITY AND INCREASED STRUCTURAL VARIATION
Neuro-Oncology·2024Open Access
page 1 of 29Next →

Frequent Co-authors

Nhan L. Tran(15), Mitsutoshi Nakada(9), Wendy S. McDonough(8), Harshil Dhruv(6), Tim Demuth(6), Dominique B. Hoelzinger(6), Alf Giese(5), Jill S. Barnholtz‐Sloan(4), Justin D. Lathia(4), Stephen W. Coons(4), Marc Symons(4), Christian Beaudry(4), Bodour Salhia(3), Melinda A. Loo(3), Joshua B. Rubin(3), Luigi Mariani(3), Theresa J. Berens(3), Michael D. Prados(3), Jeffrey M. Trent(3), Winnie S. Liang(3)